These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10514272)

  • 41. The conformational properties of the highly selective cannabinoid receptor ligand CP-55,940.
    Xie XQ; Melvin LS; Makriyannis A
    J Biol Chem; 1996 May; 271(18):10640-7. PubMed ID: 8631869
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evidence against cannabinoid receptor involvement in intraocular pressure effects of cannabinoids in rabbits.
    Hodges LC; Reggio PH; Green K
    Ophthalmic Res; 1997; 29(1):1-5. PubMed ID: 9112260
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aminoalkylindole binding in rat cerebellum: selective displacement by natural and synthetic cannabinoids.
    Kuster JE; Stevenson JI; Ward SJ; D'Ambra TE; Haycock DA
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1352-63. PubMed ID: 8450470
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term effects on cortical glutamate release induced by prenatal exposure to the cannabinoid receptor agonist (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinyl-methyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone: an in vivo microdialysis study in the awake rat.
    Antonelli T; Tanganelli S; Tomasini MC; Finetti S; Trabace L; Steardo L; Sabino V; Carratu MR; Cuomo V; Ferraro L
    Neuroscience; 2004; 124(2):367-75. PubMed ID: 14980386
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Toxicokinetics of new psychoactive substances: plasma protein binding, metabolic stability, and human phase I metabolism of the synthetic cannabinoid WIN 55,212-2 studied using in vitro tools and LC-HR-MS/MS.
    Mardal M; Gracia-Lor E; Leibnitz S; Castiglioni S; Meyer MR
    Drug Test Anal; 2016 Oct; 8(10):1039-1048. PubMed ID: 26810883
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel role of cannabinoids: implication in the fever induced by bacterial lipopolysaccharide.
    Benamar K; Yondorf M; Meissler JJ; Geller EB; Tallarida RJ; Eisenstein TK; Adler MW
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1127-33. PubMed ID: 17194800
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cannabinoid CB1 receptor-mediated inhibition of the neurogenic vasopressor response in the pithed rat.
    Malinowska B; Godlewski G; Bucher B; Schlicker E
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Aug; 356(2):197-202. PubMed ID: 9272725
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects.
    Wallace MJ; Wiley JL; Martin BR; DeLorenzo RJ
    Eur J Pharmacol; 2001 Sep; 428(1):51-7. PubMed ID: 11779037
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Homology model of the CB1 cannabinoid receptor: sites critical for nonclassical cannabinoid agonist interaction.
    Shim JY; Welsh WJ; Howlett AC
    Biopolymers; 2003; 71(2):169-89. PubMed ID: 12767117
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mutational analysis and molecular modelling of the antagonist SR 144528 binding site on the human cannabinoid CB(2) receptor.
    Gouldson P; Calandra B; Legoux P; Kernéis A; Rinaldi-Carmona M; Barth F; Le Fur G; Ferrara P; Shire D
    Eur J Pharmacol; 2000 Jul; 401(1):17-25. PubMed ID: 10915832
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Binding of aminoalkylindoles to noncannabinoid binding sites in NG108-15 cells.
    Stark S; Pacheco MA; Childers SR
    Cell Mol Neurobiol; 1997 Oct; 17(5):483-93. PubMed ID: 9353590
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of Win 55,212-2 on hippocampal CA1 long-term potentiation in experiments controlled for basal glutamatergic synaptic transmission.
    Diana G; Pieri M; Valentini G
    Eur J Pharmacol; 2002 Oct; 453(2-3):251-4. PubMed ID: 12398912
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chemically distinct ligands promote differential CB1 cannabinoid receptor-Gi protein interactions.
    Mukhopadhyay S; Howlett AC
    Mol Pharmacol; 2005 Jun; 67(6):2016-24. PubMed ID: 15749995
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antitussive effect of WIN 55212-2, a cannabinoid receptor agonist.
    Morita K; Kamei J
    Eur J Pharmacol; 2003 Aug; 474(2-3):269-72. PubMed ID: 12921873
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of cannabinoids on synaptic transmission in the rat hippocampal slice is temperature-dependent.
    Al-Hayani A; Davies SN
    Eur J Pharmacol; 2002 May; 442(1-2):47-54. PubMed ID: 12020681
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Behavioral sensitization to heroin by cannabinoid pretreatment in the rat.
    Pontieri FE; Monnazzi P; Scontrini A; Buttarelli FR; Patacchioli FR
    Eur J Pharmacol; 2001 Jun; 421(3):R1-3. PubMed ID: 11516439
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of cannabimimetic effects of structural analogs of anandamide in rats.
    Wiley JL; Ryan WJ; Razdan RK; Martin BR
    Eur J Pharmacol; 1998 Aug; 355(2-3):113-8. PubMed ID: 9760024
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analgesic, respiratory and heart rate effects of cannabinoid and opioid agonists in rhesus monkeys: antagonist effects of SR 141716A.
    Vivian JA; Kishioka S; Butelman ER; Broadbear J; Lee KO; Woods JH
    J Pharmacol Exp Ther; 1998 Aug; 286(2):697-703. PubMed ID: 9694923
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular mechanisms of cannabinoid protection from neuronal excitotoxicity.
    Kim SH; Won SJ; Mao XO; Jin K; Greenberg DA
    Mol Pharmacol; 2006 Mar; 69(3):691-6. PubMed ID: 16299067
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol.
    McMahon LR
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1211-8. PubMed ID: 16943255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.